Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Gross Profit (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Gross Profit of $2.15 billion for Q2 2026, up 2.4% from $2.1 billion a year earlier and up 9.2% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Gross Profit (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Teva Pharmaceutical Industries' Gross Profit came in at $9.09 billion, up 10.1% year-over-year; for FY2025, it was $8.94 billion, up 10.8% from FY2024.

  • Gross Profit has increased for three consecutive years, with a five-year compound annual growth rate of 3.0% (FY2020 to FY2025).
  • By year, Gross Profit came in at $8.06 billion in FY2024 (+5.5%), $7.65 billion in FY2023 (+9.6%), $6.97 billion in FY2022 (-8.2%) and $7.59 billion in FY2021 (-1.7%).
  • Five-year quarterly Gross Profit spans a low of $1.58 billion in Q1 2023 and a high of $2.66 billion in Q4 2025.
  • Year over year, Gross Profit has now increased in each of the last six quarters, with growth averaging 6.7% over the last eight quarters.
  • The high point for year-over-year Gross Profit in five years was Q4 2023 (growth of 36.4%); the low point was Q4 2022 (a decline of 13.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.97 billion (Q1 2026), $2.66 billion (Q4 2025) and $2.3 billion (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
API Access

Teva Pharmaceutical Industries Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=TEVA&period=max&api_key=YOUR_API_KEY